Related content

Impact of the -675 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene on childhood IgA nephropathy

By      

Experimental and Therapeutic Medicine, Vol. 3, Iss. 4, 2012-01 ,pp. : 703-706

Spandidos Publications

Access to resources Recommend Favorite

PAI-1 promoter 4G/5G polymorphism (rs1799768) contributes to tumor susceptibility: Evidence from meta-analysis

By                        

Experimental and Therapeutic Medicine, Vol. 4, Iss. 6, 2012-01 ,pp. : 1127-1133

Spandidos Publications

Access to resources Recommend Favorite

Expression of urokinase plasminogen activator and plasminogen activator inhibitor type-1 in ovarian cancer and its clinical significance

By          

Oncology Reports, Vol. 29, Iss. 2, 2013-01 ,pp. : 637-645

Spandidos Publications

Access to resources Recommend Favorite

Physiological and pathological changes of plasma urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor levels in healthy females and breast cancer patients

By Chung Hyun   Rha Sun   Park Joon   Yoo Nae   Kim Joo   Roh Jae   Min Jin   Lee Kyong   Kim Byung   Kim Jin  

Breast Cancer Research and Treatment, Vol. 49, Iss. 1, 1998-05 ,pp. : 41-50

Springer Publishing Company

Access to resources Recommend Favorite

+ 252A/G polymorphism in lymphotoxin-α gene influences long-term survival in patients with myelodysplastic syndrome with excess blasts

By Xu Junqing   Wang Jieyu   Ai Xiaofei   Xu Zefeng   Qin Tiejun   Fang Liwei   Zhang Hongli   Pan Lijuan   Hu Naibo   Zhang Yue   Xiao Zhijian  

Leukemia and Lymphoma, Vol. 55, Iss. 6, 2014-06 ,pp. : 1406-1407

Informa Healthcare

Access to resources Recommend Favorite